2/4
07:05 am
celc
Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026
Medium
Report
Celcuity to Present at Upcoming Guggenheim Emerging Outlook: Biotech Summit 2026
2/2
03:51 pm
celc
Oppenheimer Notes Relay Therapeutics (RLAY) Pipeline Strength in Mutant-Selective Inhibitors [Yahoo! Finance]
Low
Report
Oppenheimer Notes Relay Therapeutics (RLAY) Pipeline Strength in Mutant-Selective Inhibitors [Yahoo! Finance]
2/2
09:57 am
celc
Celcuity (CELC) Draws Investor Attention as Precision Oncology Strategy Advances [Yahoo! Finance]
Low
Report
Celcuity (CELC) Draws Investor Attention as Precision Oncology Strategy Advances [Yahoo! Finance]
1/28
06:42 am
celc
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism [Seeking Alpha]
Low
Report
Oppenheimer Upgrade Fuels Relay Therapeutics Rally On Zovegalisib Optimism [Seeking Alpha]
1/23
01:46 pm
celc
Celcuity Inc.: A Die To Be Cast Before July 2026 [Seeking Alpha]
Low
Report
Celcuity Inc.: A Die To Be Cast Before July 2026 [Seeking Alpha]
1/21
09:30 pm
celc
Reassessing Celcuity (CELC) Valuation After A 51.85% Three Month Share Price Gain [Yahoo! Finance]
Medium
Report
Reassessing Celcuity (CELC) Valuation After A 51.85% Three Month Share Price Gain [Yahoo! Finance]
1/20
10:26 am
celc
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer [Yahoo! Finance]
Low
Report
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer [Yahoo! Finance]
1/20
07:30 am
celc
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
Low
Report
Celcuity Announces FDA Acceptance of New Drug Application for Gedatolisib in HR+/HER2-/PIK3CA Wild-Type Advanced Breast Cancer
1/11
01:18 am
celc
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) [Yahoo! Finance]
Low
Report
Wells Fargo Initiates Coverage On Celcuity Inc. (CELC) [Yahoo! Finance]
1/2
03:41 am
celc
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results [Yahoo! Finance]
Low
Report
Celcuity (CELC) Surges 662% in 2025 on Breast Cancer Treatment Trial Results [Yahoo! Finance]
12/24
11:27 am
celc
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond [Seeking Alpha]
Low
Report
Celcuity: After Stellar 2025, I Predict More Success In 2026 And Beyond [Seeking Alpha]
12/17
10:32 am
celc
How Investors Are Reacting To Celcuity (CELC) Gedatolisib's Phase 3 Breast Cancer Data And Safety Profile [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Celcuity (CELC) Gedatolisib's Phase 3 Breast Cancer Data And Safety Profile [Yahoo! Finance]
12/16
09:27 pm
celc
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation [Yahoo! Finance]
Low
Report
Celcuity (CELC): Fresh Phase 3 Breast Cancer Data Prompts Closer Look at Gedatolisib-Driven Valuation [Yahoo! Finance]
12/13
07:49 am
celc
Celcuity (NASDAQ:CELC) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
Medium
Report
Celcuity (NASDAQ:CELC) was upgraded by analysts at Wells Fargo & Company to a "strong-buy" rating.
12/12
07:12 am
celc
Celcuity (NASDAQ:CELC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
Medium
Report
Celcuity (NASDAQ:CELC) is now covered by analysts at Wells Fargo & Company. They set an "overweight" rating on the stock.
12/11
03:16 pm
celc
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Low
Report
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
12/11
02:35 pm
celc
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
Low
Report
Celcuity Presents Updated Results from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
12/2
08:04 am
celc
Celcuity (NASDAQ:CELC) had its price target raised by analysts at Jefferies Financial Group Inc. from $108.00 to $134.00. They now have a "buy" rating on the stock.
Low
Report
Celcuity (NASDAQ:CELC) had its price target raised by analysts at Jefferies Financial Group Inc. from $108.00 to $134.00. They now have a "buy" rating on the stock.
11/28
11:26 pm
celc
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge [Yahoo! Finance]
Low
Report
Celcuity (CELC): Assessing Valuation Following Recent Share Price Surge [Yahoo! Finance]
11/28
07:33 am
celc
Celcuity: From Speculative Bet To Pre-Commercial Powerhouse [Seeking Alpha]
Low
Report
Celcuity: From Speculative Bet To Pre-Commercial Powerhouse [Seeking Alpha]
11/27
05:44 pm
celc
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results [Yahoo! Finance]
Low
Report
This Fund Bought $38 Million of Celcuity as Stock Surges on Investigational Cancer Drug Results [Yahoo! Finance]
11/26
05:38 pm
celc
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
Low
Report
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium [Yahoo! Finance]
11/26
04:05 pm
celc
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
Low
Report
Celcuity to Present Updated Data from the PIK3CA Wild-Type Cohort of the Phase 3 VIKTORIA-1 Trial at the 2025 San Antonio Breast Cancer Symposium
11/26
07:13 am
celc
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
Low
Report
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference [Yahoo! Finance]
11/26
07:05 am
celc
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference
Low
Report
Celcuity To Present at Upcoming 8th Annual Evercore Healthcare Conference